AMB-FUBINACA (also known as FUB-AMB and MMB-FUBINACA) is an indazole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug. It was originally developed by Pfizer which described the compound in a patent in 2009, but was later abandoned and never tested on humans.
Molecular weight: 302.39
Compound purity: > 99.7%
Related substance: Total Impurities(%) ≤ 0.3%
1.Best quality in your requirement.
2.Competitive price for your market.
3.Mature technial supporting.
4.Fast delivery within one week
5.Perfect after-sell service.
my contact infomation is:
Notice: This product is only suitable for laboratory use, or the use of animals. It can not be used directly on the human body